Search research articles
Contact Us
Filters
Showing results (141-150 of 166) with videos related to
Page
of 17
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2017
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor
G Siravegna, A Sartore-Bianchi, B Mussolin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas
R K Ramanathan, D Goldstein, R L Korn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
S Siena, A Sartore-Bianchi, R Garcia-Carbonero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
M D Green, H Koelbl, J Baselga, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2005
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies
A Zambelli, D Lilleri, P Pedrazzoli, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Germline genomic profiling of patients with early-onset colorectal cancer
G Mauri, M Puzzono, A Mannucci, et al.
British Journal of Cancer
|
September 24, 2009
Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)
C Pinto, F Di Fabio, C Barone, et al.
Breast (Edinburgh, Scotland)
|
January 21, 2004
Breast cancer at the end of a successful century: meeting highlights from the First Milan Breast Cancer Conference and discussion paper for the Second Conference (Milan, 14-16 June, 2000)
U Veronesi, A Costa, S Zurrida, et al.
ESMO Open
|
October 2, 2024
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study
F Tosi, L Salvatore, E Tamburini, et al.
ESMO Open
|
December 17, 2021
Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management
P Vallerio, A Orenti, F Tosi, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 166) with videos related to
Sort By:
Page
of 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 4, 2017
Tracking a CAD-ALK gene rearrangement in urine and blood of a colorectal cancer patient treated with an ALK inhibitor
G Siravegna, A Sartore-Bianchi, B Mussolin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2016
Positron emission tomography response evaluation from a randomized phase III trial of weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas
R K Ramanathan, D Goldstein, R L Korn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
S Siena, A Sartore-Bianchi, R Garcia-Carbonero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2002
A randomized double-blind multicenter phase III study of fixed-dose single-administration pegfilgrastim versus daily filgrastim in patients receiving myelosuppressive chemotherapy
M D Green, H Koelbl, J Baselga, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 3, 2005
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies
A Zambelli, D Lilleri, P Pedrazzoli, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Germline genomic profiling of patients with early-onset colorectal cancer
G Mauri, M Puzzono, A Mannucci, et al.
British Journal of Cancer
|
September 24, 2009
Phase II study of cetuximab in combination with cisplatin and docetaxel in patients with untreated advanced gastric or gastro-oesophageal junction adenocarcinoma (DOCETUX study)
C Pinto, F Di Fabio, C Barone, et al.
Breast (Edinburgh, Scotland)
|
January 21, 2004
Breast cancer at the end of a successful century: meeting highlights from the First Milan Breast Cancer Conference and discussion paper for the Second Conference (Milan, 14-16 June, 2000)
U Veronesi, A Costa, S Zurrida, et al.
ESMO Open
|
October 2, 2024
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study
F Tosi, L Salvatore, E Tamburini, et al.
ESMO Open
|
December 17, 2021
Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management
P Vallerio, A Orenti, F Tosi, et al.
Page
of 17